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Background
Patients with primary immunodeficiencies (PIDs) are at
high risk for potentially serious infectious and noninfec-
tious complications. Early diagnosis and proper treatment
enables better quality of life and survival. The aim of this
study was to describe the profile and prognosis of adoles-
cents and adults with PIDs in follow-up in a public hospi-
tal of Rio de Janeiro, Brazil.
Methods
A retrospective study evaluating patients treated
between 1997 and 2014 with a diagnosis of PID, aged >
12 years and in regular follow-up for > 1 year. The clas-
sification of the International Union of Immunological
Societies Expert Committee for Primary Immunodefi-
ciency in 2013 was used. Demographics, PIDs profile,
time to diagnosis, treatment adherence and survival
were analyzed.
Results
33 patients were analyzed: 55% female, 70% Caucasian,
27% Black, and 3% Asian, with ages between 12 and 64
years (mean = 36.7, SD = 11) and length of follow-up
between 1 and 17 years (mean = 8.84, SD = 11.29). The
profile and frequency of PIDs was as follows: Predomi-
nantly antibody deficiencies (55%), Combined immunode-
ficiencies less profound than generally severe combined
immunodeficiency (18%) Combined immunodeficiencies
associated with features or syndromic (15%), Complement
deficiencies (9%), and Autoinflammatory disorders (3%).
The average time between onset of symptoms and diagno-
sis of PID ranged between 1 and 28 years (mean = 10.83,
SD = 7.07). Compliance with treatment was good in 76%
of patients, partial in 12% and 12% of treatment dropout.
Survival between the onset of clinical manifestations and
the end of the study ranged between 1 and 47 years (mean
= 21.52, SD =13.79). Throughout the study period, one
patient, with Wiskott-Aldrich syndrome and partial adher-
ence to treatment, died due to septicemia and there were
two deaths from cardiovascular disease.
Conclusions
We observed that most patients were Caucasians, which
differs from the racial distribution of the population of
Rio de Janeiro, indicating the possibility of underdiagno-
sis in Black or lesser frequency of PID in this racial
group population. Among the subgroups of PIDs, the
predominantly antibody deficiencies occurred more
often, which is in agreement with the international lit-
erature. A high percentage of patients showed good
adherence to treatment, along with long-term survival.
We found a great delay in diagnosis, which indicates the
importance of training general practitioners and specia-
lists for diagnostic screening of PIDs.
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